ImmunoPrecise Antibodies Shares Outstanding 2022-2024 | IPA

ImmunoPrecise Antibodies shares outstanding from 2022 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

ImmunoPrecise Antibodies Shares Outstanding 2022-2024 | IPA

ImmunoPrecise Antibodies shares outstanding from 2022 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.